INMD
InMode Ltd. · Healthcare · Medical Devices
Last
$13.75
−$0.30 (−2.14%) 4:00 PM ET
After hours $13.86 +$0.11 (+0.80%) 11:34 PM ET
Prev close $14.05
Open $13.97
Day high $13.97
Day low $13.74
Volume 807,804
Avg vol 1,282,887
Mkt cap
$871.18M
P/E ratio
20.52
FY Revenue
$231.19M
EPS
0.67
Gross Margin
84.97%
Sector
Healthcare
AI report sections
INMD
InMode Ltd.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
−17% (Below avg)
Vol/Avg: 0.83×
RSI
42.91 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
-0.00 (Weak)
MACD: -0.00 Signal: -0.00
Short-Term
-0.11 (Weak)
MACD: -0.17 Signal: -0.06
Long-Term
-0.10 (Weak)
MACD: -0.05 Signal: 0.05
Intraday trend score 23.00

Latest news

INMD 12 articles Positive: 3 Neutral: 1 Negative: 2
Positive GlobeNewswire Inc. • Researchandmarkets.Com
Energy-Based Aesthetic Devices Market Research Report 2026-2031: Advancements in Laser and RF Systems, Rising Consumer Demand and Geographic Expansion Accelerate Revenue Opportunities

The Energy-Based Aesthetic Devices Market is projected to grow from USD 7.03 billion in 2025 to USD 11.80 billion by 2031 at a CAGR of 9.02%. Growth is driven by increased demand for hair removal treatments, med-spa expansion, minimally invasive procedures, and AI integration. Laser-based technology dominates the market, with North America leading globally. Key challenges include rising health and wellness awareness and high device costs.

BHC INMD energy-based aesthetic devices laser technology hair removal med-spa minimally invasive treatments AI integration
Sentiment note

Listed as a key vendor in the growing energy-based aesthetic devices market with opportunities from technological innovations and geographic expansion.

Negative Benzinga • Anthony Noto
Deal Dispatch: Musk Merger Talk, LIV Golf Stakes, And A Flurry Of M&A From AI To Athleisure

Major M&A activity spans multiple sectors: Elon Musk reportedly weighs merging SpaceX, Tesla, and xAI; C3.ai is in merger talks with Automation Anywhere; Anta Sports acquires 29% stake in Puma for €1.51 billion; Steel Partners offers $1.1 billion for InMode controlling stake; LIV Golf seeks minority investors for team stakes; and First Brands Group founders face fraud charges related to bankruptcy.

TSLA AI ANPDY PUMSY merger acquisition M&A SpaceX
Sentiment note

Steel Partners' unsolicited offer at $18/share (29% premium) signals criticism of management performance, stock underperformance, and repeated guidance cuts; represents potential loss of independence.

Negative Benzinga • Vandana Singh
Steel Partners Targets InMode, Citing Stock Underperformance

Steel Partners Holdings has made an unsolicited proposal to acquire a controlling 51% stake in InMode Ltd. at $18 per share, representing a 29% premium to the stock's January 23 closing price. The acquisition proposal cites InMode's poor stock performance (negative 19.18% over one year), repeated guidance cuts (seven reductions in nine quarters), and inefficient capital allocation despite holding $532.3 million in cash with no debt. Steel Partners, already a 1.3% shareholder, stated it will pursue a binding offer directly to shareholders if discussions don't progress.

INMD acquisition proposal unsolicited bid stock underperformance guidance cuts capital allocation cash reserves shareholder value
Sentiment note

InMode faces an unsolicited takeover bid due to significant underperformance, with negative total shareholder returns of -19.18% (1-year), -59.35% (3-year), and -53.24% (5-year). The company has issued seven guidance cuts in nine quarters and is criticized for poor capital allocation despite substantial cash holdings. While the stock rose 5.82% on the acquisition news, the underlying business fundamentals and reasons for the bid are negative.

Positive Benzinga • Prnewswire
InMode to Participate in Upcoming Investor Conferences

InMode Ltd. announced participation in two investor conferences in August 2025, including the Needham Virtual MedTech & Diagnostics Conference and Canaccord 45th Annual Global Growth Conference, featuring presentations by their CEO and CFO.

INMD investor conferences medical technologies radio frequency medical devices
Sentiment note

Company is proactively engaging with investors through multiple conference presentations, showcasing confidence in their business and technology offerings across multiple medical specialties

Positive GlobeNewswire Inc. • Custom Market Insights
[Latest] Global Cosmetic Surgery Market Size/Share Worth USD 207.6 Billion by 2033 at a 11.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

The global cosmetic surgery market is expected to grow from $67.2 billion in 2023 to $207.6 billion by 2033, at a CAGR of 11.7%. The market is driven by the growing acceptability and desire for less invasive treatments, with surgical procedures and the female segment holding the highest market share.

ESTA GALDY ZBH INMD cosmetic surgery market size growth rate trends
Sentiment note

InMode Ltd. is listed as a key player in the cosmetic surgery market, indicating its significant presence in the industry.

Neutral The Motley Fool • The Motley Fool
InMode (INMD) Q3 2024 Earnings Call Transcript

InMode reported Q3 2024 earnings, with revenue and guidance missing expectations due to macroeconomic headwinds and a slowdown in minimally invasive treatments. The company is optimistic about its new platforms, IgniteRF and OptimasMAX, and is making organizational changes to align its target market.

INMD InMode earnings macroeconomic headwinds minimally invasive IgniteRF OptimasMAX
Sentiment note

InMode reported mixed results, with revenue and guidance missing expectations due to macroeconomic factors, but the company is optimistic about its new product offerings and is making organizational changes to adapt to the market conditions.

Unknown Seeking Alpha • EQ Research
InMode: Facing A Myraid Of Headwinds

InMode's business seems heavily reliant on economic conditions, beyond management's control. See why INMD stock is a Hold.

INMD
Unknown The Motley Fool • newsfeedback@fool.com (Motley Fool Transcribing)
InMode (INMD) Q1 2024 Earnings Call Transcript

INMD earnings call for the period ending March 31, 2024.

INMD earningscall-transcripts
Unknown Zacks Investment Research • Zacks Equity Research
TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates

TG Therapeutics (TGTX) delivered earnings and revenue surprises of -133.33% and 15.59%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

TGTX INMD
Unknown Zacks Investment Research • Zacks Equity Research
Stryker (SYK) Beats Q1 Earnings and Revenue Estimates

Stryker (SYK) delivered earnings and revenue surprises of 6.38% and 3.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

SYK INMD
Unknown Zacks Investment Research • Zacks Equity Research
Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline

InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

INMD
Unknown The Motley Fool • newsfeedback@fool.com (Motley Fool Staff)
Nuvei's Going Private

We also check in on the latest Tesla news.

TSLA TM INMD NVEI investing
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal